Related Experiment Video
Updated: Mar 27, 2026

Combined Conditional Knockdown and Adapted Sphere Formation Assay to Study a Stemness-Associated Gene of Patient-derived Gastric Cancer Stem Cells
Published on: May 9, 2020
The cGAS-STING pathway in cancer: friend or foe
Qian Li1,2,3,4, Qingkang Song1,2,3,4, Lingli Ma1,2,3,4
1NHC Key Laboratory of Carcinogenesis and Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Abstract:
The cGAS-STING pathway is crucial for recognizing aberrant DNA in the cytoplasm and activating the innate immune response. After detecting aberrant DNA in the cytoplasm, cGAS can catalyze the synthesis of cGAMP from ATP and GTP, which acts as a second messenger to engage STING and unleash type I interferons, thereby eliciting a robust antitumor immune cascade. In recent years, the role of the cGAS-STING pathway in tumor immunity has attracted widespread attention. Paradoxically, it not only activates antitumor immune responses but also promotes tumor progression under certain circumstances. This review untangles the safeguards that prevent cGAS from recognizing nuclear self-DNA, delineates the antitumor and pro-tumor mechanisms of the cGAS-STING axis, and surveys tumor immunotherapy strategies targeting this pathway.
Insights
The cyclic GMP-AMP synthase (cGAMP) synthase (cGAS)-stimulator of interferon genes (STING) pathway detects cytoplasmic DNA to trigger immunity. This pathway has dual roles in cancer, activating anti-tumor responses while sometimes promoting tumor growth.
Area of Science:
- Immunology
- Molecular Biology
- Cancer Research
Background:
- The cGAS-STING pathway is a key innate immune sensor for aberrant cytoplasmic DNA.
- Activation of cGAS by DNA leads to the production of cGAMP, which signals through STING to induce type I interferons.
- This pathway plays a complex role in tumor immunity, with both anti-tumor and pro-tumor effects.
Purpose of the Study:
- To review the mechanisms by which the cGAS-STING pathway is regulated.
- To delineate the dual roles of the cGAS-STING axis in tumor immunity.
- To survey immunotherapy strategies targeting the cGAS-STING pathway.
Main Methods:
- Literature review of studies on the cGAS-STING pathway in cancer.
- Analysis of mechanisms controlling cGAS activation and STING signaling.
- Evaluation of evidence for both anti-tumor and pro-tumor functions.
Main Results:
- The review clarifies safeguards preventing cGAS from sensing nuclear self-DNA.
- It details how the cGAS-STING pathway can both promote anti-tumor immunity and support tumor progression.
- Various immunotherapy strategies targeting this axis are discussed.
Conclusions:
- The cGAS-STING pathway is a critical regulator of the tumor immune microenvironment.
- Understanding its dual functions is essential for developing effective cancer immunotherapies.
- Targeting the cGAS-STING pathway holds significant promise for cancer treatment.
More Related Videos
09:01Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
Published on: July 3, 2025
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Intracellular Signaling Cascades
Cancer Cell Migration through Invadopodia
The Intrinsic Apoptotic Pathway